Which companies discussed Clinical Trials in Health Care in earnings calls?

1,112 companies mentioned clinical trials across 3,753 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Ionis Pharmaceuticals, Inc. (22 calls), Merck KGaA (21 calls), Exelixis, Inc. (19 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning Clinical Trials
2024Q3719
2024Q4828
2025Q1985
2025Q2738
2025Q3873
2025Q4883
2026Q11,056
2026Q2931
2026Q330

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Ionis Pharmaceuticals, Inc. IONS Health Care 22 Jun 24, 2026
Merck KGaA MRK Health Care 21 Jun 9, 2026
Exelixis, Inc. EXEL Health Care 19 Jun 9, 2026
Roivant Sciences Ltd. ROIV Health Care 19 Jun 9, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 19 Jun 8, 2026
Incyte Corporation INCY Health Care 18 Jun 9, 2026
Insmed Incorporated INSM Health Care 17 Jul 16, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 17 Jul 6, 2026
PTC Therapeutics, Inc. PTCT Health Care 17 Jun 9, 2026
Biogen Inc. BIIB Health Care 16 Jul 12, 2026
Rhythm Pharmaceuticals, Inc. RYTM Health Care 16 Jun 13, 2026
Neurocrine Biosciences, Inc. NBIX Health Care 16 Jun 9, 2026
Johnson & Johnson JNJ Health Care 15 Jul 15, 2026
Alnylam Pharmaceuticals, Inc. ALNY Health Care 15 Jun 25, 2026
Amgen Inc. AMGN Health Care 15 Jun 9, 2026
Gilead Sciences, Inc. GILD Health Care 15 Jun 9, 2026
Natera, Inc. NTRA Health Care 15 Jun 8, 2026
United Therapeutics Corporation UTHR Health Care 15 Jun 3, 2026
Moderna, Inc. MRNA Health Care 14 Jun 25, 2026
Kura Oncology, Inc. KURA Health Care 14 Jun 12, 2026
Recursion Pharmaceuticals, Inc. RXRX Health Care 14 Jun 9, 2026
Ultragenyx Pharmaceutical Inc. RARE Health Care 14 Jun 9, 2026
Jazz Pharmaceuticals plc JAZZ Health Care 14 Jun 3, 2026
Cencora, Inc. COR Health Care 14 May 13, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 13 Jun 29, 2026
AbbVie Inc. ABBV Health Care 13 Jun 9, 2026
Nurix Therapeutics, Inc. NRIX Health Care 13 Jun 8, 2026
BridgeBio Pharma, Inc. BBIO Health Care 13 May 12, 2026
Genmab A/S GMAB Health Care 13 May 7, 2026
Bio-Techne Corporation TECH Health Care 13 May 6, 2026
Telix Pharmaceuticals Limited TLX Health Care 12 Jun 29, 2026
GSK plc GSK Health Care 12 Jun 9, 2026
Denali Therapeutics Inc. DNLI Health Care 12 Jun 9, 2026
Bristol-Myers Squibb Company BMY Health Care 12 Jun 9, 2026
Cytokinetics, Incorporated CYTK Health Care 12 Jun 8, 2026
Axsome Therapeutics, Inc. AXSM Health Care 12 Jun 8, 2026
Nuvation Bio Inc. NUVB Health Care 12 Jun 3, 2026
Absci Corporation ABSI Health Care 12 May 7, 2026
Celcuity Inc. CELC Health Care 11 Jul 14, 2026
Syndax Pharmaceuticals, Inc. SNDX Health Care 11 Jul 14, 2026
CRISPR Therapeutics AG CRSP Health Care 11 Jun 9, 2026
Tempus AI, Inc. TEM Health Care 11 Jun 8, 2026
Pfizer Inc. PFE Health Care 11 Jun 8, 2026
Travere Therapeutics, Inc. TVTX Health Care 11 Jun 8, 2026
Oncolytics Biotech Inc. ONC Health Care 11 Jun 8, 2026
Summit Therapeutics Inc. SMMT Health Care 11 Jun 8, 2026
Wave Life Sciences Ltd. WVE Health Care 11 Jun 8, 2026
AbCellera Biologics Inc. ABCL Health Care 11 Jun 4, 2026
Certara, Inc. CERT Health Care 11 Jun 3, 2026
Medtronic plc MDT Health Care 11 Jun 3, 2026

Representative quotes

…steady cadence over the next 12 months. We also remain on track to begin patient enrollment in the fourth quarter for several important clinical trials that will support a steady cadence of future product launches and these include a balloon expandable TAVR valve, a leadless conduction system pacing…
Abbott Laboratories (ABT), July 16, 2026. Read the full transcript →
…positive results. IZIPRY, we are well on track to file in Q3 in September. OX640, we're on track to start the clinical trial that we are scheduled in for Q4 this year. We are also, during the quarter, we started where -- we can call them early stage…
Orexo AB (publ) (ORX), July 16, 2026. Read the full transcript →
…fact, a 2-point reduction is probably the largest reduction in REVEAL risk score that I have seen throughout many of the clinical trials that I participated in. And achieving ultra-low risk, which we define as a REVEAL score less than 4, not only ensures that…
Insmed Incorporated (INSM), July 16, 2026. Read the full transcript →
…growing presence in Japan. And we completed enrollment in the PACIFICA trial of ongoing chronic myelofibrosis, which we already discussed at the last earnings call. Next slide, please. Turning to gout. Clinical results for Podetinura strengthened our decision to make this asset part of the Sobi portfolio…
Swedish Orphan Biovitrum AB (publ) (SOBI), July 16, 2026. Read the full transcript →

Frequently asked questions

What is Clinical Trials and why are companies discussing it?

Pipeline readouts, trial milestones and FDA commentary driving biotech and pharma valuations.

Which company mentioned clinical trials most in Health Care in the past year?

Ionis Pharmaceuticals, Inc. (IONS) led with 22 calls referencing clinical trials, most recently on June 24, 2026.

How can I track clinical trials mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related healthcare themes

Last updated: July 16, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (clinical trial, clinical trial, clinical trials, phase 3). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.